Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
997.6 INR | -0.51% | -2.60% | +40.06% |
24/05 | Transcript : Orchid Pharma Limited, Q4 2024 Earnings Call, May 24, 2024 | |
23/05 | Orchid Pharma Limited Appoints Shubha Singh as Additional Director | CI |
Sales 2024 | 819.37Cr 9.86Cr | Sales 2025 * | 1.03TCr 12Cr | Capitalization | 5.09TCr 61Cr |
---|---|---|---|---|---|
Net income 2024 | 92Cr 1.11Cr | Net income 2025 * | 148.6Cr 1.79Cr | EV / Sales 2024 | 6.31 x |
Net cash position 2024 | 132.09Cr 1.59Cr | Net cash position 2025 * | 164.8Cr 1.98Cr | EV / Sales 2025 * | 4.78 x |
P/E ratio 2024 |
72.1
x | P/E ratio 2025 * |
34
x | Employees | 838 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 26.03% |
Latest transcript on Orchid Pharma Limited
1 day | -0.47% | ||
1 week | -2.60% | ||
Current month | -0.47% | ||
1 month | -4.42% | ||
3 months | -16.22% | ||
6 months | +72.33% | ||
Current year | +40.06% |
Managers | Title | Age | Since |
---|---|---|---|
Manish Dhanuka
CEO | Chief Executive Officer | 56 | 31/20/31 |
Director of Finance/CFO | - | 29/20/29 | |
Kapil Dayya
CMP | Compliance Officer | - | 16/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 74 | 31/20/31 | |
Mridul Dhanuka
BRD | Director/Board Member | 42 | 31/20/31 |
Manish Dhanuka
CEO | Chief Executive Officer | 56 | 31/20/31 |
Date | Price | Change | Volume |
---|---|---|---|
03/24/03 | 997.6 | -0.51% | 36 718 |
31/24/31 | 1,003 | -0.33% | 300,794 |
30/24/30 | 1,006 | -2.17% | 324,158 |
29/24/29 | 1,028 | -0.11% | 44,550 |
28/24/28 | 1,030 | +0.49% | 74,918 |
Delayed Quote NSE India S.E., June 03, 2024 at 01:38 pm IST
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+40.06% | 61Cr | |
+40.73% | 74TCr | |
+31.74% | 60TCr | |
-6.30% | 35TCr | |
+15.15% | 32TCr | |
+4.05% | 28TCr | |
+14.17% | 24TCr | |
+9.18% | 21TCr | |
-5.24% | 21TCr | |
+6.17% | 16TCr |
- Stock Market
- Equities
- ORCHPHARMA Stock